Braveheart Bio, Inc. · NASDAQ:BRVE

AH Bio Fund IV, L.P. reported a 11.40% stake in Braveheart Bio, Inc. (Schedule 13D)

Event Aug 7, 2026 · Filed Aug 14, 2026

AH Bio Fund IV, L.P. reported a 11.40% stake in Braveheart Bio, Inc., 10,232,420 shares, with active intent on Aug 7, 2026. Filed Aug 14, 2026 (Schedule 13D).

Stake
11.40%
Shares
10,232,420
Intent
Active
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
AH Bio Fund IV, L.P.11.40%10,232,420
AH Equity Partners Bio IV, L.L.C.11.40%10,232,420
Marc L. Andreessen11.40%10,232,420
Benjamin A. Horowitz11.40%10,232,420

Source

View original at SEC

Related